World Orphan Drug Alliance Expands to Japan & South Korea an

Japan, South Korea, and the African subcontinent are now covered by the Alliance. With the addition of two new WODA members – Nxera Pharma (formerly Sosei Heptares) and Veld Pharmaceuticals – WODA now provides access to over 200 million rare disease patients. TOKYO and ZUG, Switzerland, April 08, 2024 (GLOBE NEWSWIRE) -- The World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in comp

Related Keywords

Japan , Turkey , New Zealand , South Korea , Seoul , Soult Ukpyolsi , Australia , Tokyo , London , City Of , United Kingdom , Israel , Cyprus , Malta , Switzerland , South Korean , Nxera Pharma , Frazer Hall , Sandra Lambert , Patrick Jordan , Orphandc Latin America , Maya Bennison , Erica Hollingsworth , Nxerapharma Youtube , Sosei Heptares , Kentaro Tahara , Chris Cargill , Tina Vojnovic , Effrx Pharmaceuticals Switzerland , Tokyo Stock Exchange , Linkedin , World Orphan Drug Alliance , Veld Pharmaceuticals The African , Veld Pharmaceuticals , Southern Africa , Specialised Therapeutics , South East Asia , Eastern Europe , Greater China , Path Pharma , Latin America , Vector Pharma , Middle East , North Africa , Named Patient Programs , Corporate Communication , Investor Relations , Rare Disease , Pharmaceuticals , Orphan Drug , Global Alliance , Doda , Biotech Companies ,